Dostartlimab, new drug cures colorectal cancer after trial 
Early trials of a drug to treat colorectal cancer have resulted in remarkable remission in every participant.
Early trials of a drug to treat colorectal cancer have resulted in remarkable remission in every participant.
Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |